Key Research Points at a Glance A 15-amino-acid fragment of a gastric-juice-derived protective protein, first characterised in the early 1990s Primary research mechanisms: angiogenesis (VEGF pathway) and gastric/gut-lining signalling Secondary mechanisms under study: growth factor modulation (EGF, FGF) and nitric oxide system interaction Frequently co-researched with TB-500 despite acting through an unrelated mechanism The large majority of published research is pre-clinical (in-vitro and animal-model), not human clinical data Notably stable across a wider pH/temperature range than many comparable research peptides What Is BPC-157
Subnormal Concentrations of Serum Cobalamin (Vitamin B12) in Cats with Gastrointestinal Disease
Orders over $200 include free shipping
VRK2 promotes ER-to-Golgi trafficking of SLC7A11 and its expression on the cell membrane To explore the effect of VRK2 on the expression of SLC7A11, we first investigated mRNA level of SLC7A11 in VRK2 knockdown cells and found that VRK2 did not affect the transcription of SLC7A11 (Fig
Certain classical ASMs (e.g., phenobarbital, benzodiazepines, topiramate, vigabatrin) primarily act by broadly suppressing neuronal excitability or markedly enhancing GABA receptor activity
